China
Africa
Explore chapters and articles related to this topic
The menopause
Published in Michael J. O’Dowd, The History of Medications for Women, 2020
Allen and Doisy (1923) isolated an ovarian hormone, later called estrogen. Dodds and Robertson (1930) described the use of ‘estrin’, a substance derived from human placental sources, in the treatment of women with menopausal complaints. Oral estrogen therapy became widely available after the development of the semi-synthetic estrogen, stilboestrol, by Dodds and associates (1938). The semi-synthetic estrogens, ethinyl estradiol and mestranol were produced for oral contraception but also used for menopausal therapy. Natural estrogens were mainly used thereafter.
Technology and Social Media
Published in Akshaya Neil Arya, Preparing for International Health Experiences, 2017
Therefore, it is important to consider the subject being photographed in combination with the partner worked with (Estrin, 2012). Because many global health photographers are typically working with non-governmental organizations (NGOs), it is key to reflect on whether the mission of the NGO and how the photos will be used is one that you as a photographer would like to support. For example, the images captured will be used to further the left- or right-leaning goals of the newspaper or publication. As Stephen Mayes, the Director of Magnum Photo Agency states, ‘by working with them, you’re effectively endorsing that world view’ (Estrin, 2012).
Clinical Applications of Prescriptions Containing Bupleurum Root
Published in Sheng-Li Pan, Bupleurum Species, 2006
Effects and Indications: The recipe has the functions of harmonizing qi and blood, resolving phlegm to relieve depression, tranquilizing mind. Its indications are fullness in chest, vexation and anxiety, difficulty in urination, delirium, and dreaminess. Modern research has ascertained that the recipe had the activity of regulating the function of the central nervous system, protecting the cardiovascular system, lowering blood-fat, preventing atherosclerosis, promoting blood coagulation, arresting blood, and increasing the content of estrin. At present, it is mainly used to treat neurosis, epilepsy, depression, mania, hypertension, atherosclerosis, hyperthyroidism, climacteric syndrome.
Pediatric diabetes patients infrequently access outpatient psychology services following screening and referral: Implications for practice
Published in Children's Health Care, 2020
Areti Vassilopoulos, Jessica M. Valenzuela, Joanna Tsikis, Lital Reitblat, Ernesto J. Blanco, Shelley Nicholls, Risa M. Wolf
Above and beyond integrated appointments, co-location of outpatient mental health services has been shown to be helpful in improving access. Specifically, Lieberman, Adalist-Estrin, Erinle, and Sloan (2006) found that referral appointments scheduled with integrated behavioral health providers for on-site services had a 66% attendance rate, compared to 2.6% when patients were provided with external referrals. Notably, the largest proportion of integrated care research has been conducted within primary care settings. Within diabetes populations, most youth have regular appointments with their pediatric endocrinologist approximately every three to six months (ADA, 2014). Therefore, integration and service co-location within diabetes centers is likely to improve access to mental health services for youth with diabetes.
Pharmacodynamics of combined estrogen-progestin oral contraceptives 3. Inhibition of ovulation
Published in Expert Review of Clinical Pharmacology, 2018
Carlo Bastianelli, Manuela Farris, Elena Rosato, Ivo Brosens, Giuseppe Benagiano
The idea of blocking ovulation through the administration of estrogens is more than 80 years old: in 1937, Kurzrok [2] stressed that any hormonal contraceptive method acts by producing temporary sterility and that hormonal sterilization deals with methods that render the woman sterile for the duration of at least one menstrual cycle. He reported that in mice and rabbits, estrone has a depressant effect on ovarian response to FSH and that large doses of estradiol benzoate used to treat dysmenorrhea altered menstrual rhythm. A few years later, Sturgis and Albright [3] confirmed that ‘estrin’, when used to treat severe dysmenorrhea, blocked ovulation. In 1943, Lyon [64] proved that the daily administration of 50 µg EE was indeed capable of blocking ovulation, as determined by the presence of a monophasic basal body temperature recording. Initially, there was skepticism over the ability of estrogens to constantly inhibit fertility, because of what was coined at the time as ‘pituitary escape’, a concept criticized by Rudel et al. as unproven [24]. The same group presented data showing that MSN is able to inhibit ovulation at the daily dose of 80 µg, but failed to do so when given at the dose of 40 µg [65].
Hiding in Plain Sight: Insights about Health-Care Trends Gained through Open Health Data
Published in Journal of Technology in Human Services, 2018
A. Ravishankar Rao, Daniel Clarke
A central component of our research consists of an Open Source Big-Data Analytics Tool which is available freely to the research community (via github.com/fdudatamining/framework). We propose Open Source in healthcare data analytics as one of the next frontiers of innovation in healthcare (Roshan & Alexa, 2011). Open-source shareable code and algorithms can be utilized by researchers to accelerate their investigations. The wave of the future in healthcare includes open health records (Estrin & Sim, 2010) and open source (Roshan & Alexa, 2011).